Cocaine inhibits NGF-induced PC12 cells differentiation through D1-type dopamine receptors

Academic Article

Abstract

  • In utero cocaine exposure can adversely affect CNS development. Previous studies showed that cocaine inhibits neuronal differentiation in a dose-dependent fashion in nerve growth factor (NGF)-stimulated PC12 cells. Cocaine binds with high affinity to several neurotransmitter transporters, resulting in elevated neurotransmitter levels in nerve endings. To determine if cocaine inhibits neurite outgrowth through the effects of these neurotransmitters, we applied dopamine, norepinephrine, serotonin, and acetylcholine to NGF-induced PC12 cells. Dopamine was the only neurotransmitter to inhibit neurite outgrowth significantly in a dose-dependent pattern without affecting cell viability. Norepinephrine and acetylcholine did not affect neurite outgrowth, while serotonin enhanced it. Furthermore, GBR 12909, a potent dopamine transporter (DAT) inhibitor, yielded similar effects. We then showed PC12 cells express D1 and D2 receptors and DAT proteins. Dopamine uptake measured over time was significantly blocked by cocaine and GBR 12909 which may result in elevated extracellular dopamine. The role of dopamine receptors in PC12 differentiation was further examined by using D1 and D2 specific receptor agonists. Only the D1 agonist, SKF-38393, had a significant dose-dependent inhibitory effect. In addition, a D1 antagonist produced significant recovery of neurite outgrowth in cocaine-treated cells. These findings suggest that cocaine inhibitory effects on neuronal differentiation are mediated through its binding to the dopamine transporter, resulting in increased dopamine level in the synapses. Subsequently, up regulation of D1 receptors alters NGF signaling pathways. Theme: Neurotransmitters, modulators, transporters, and receptors. Topic: Catecholamine receptors. Copyright (C) 2000 Elsevier Science B.V.
  • Published In

  • Brain Research  Journal
  • Digital Object Identifier (doi)

    Author List

  • Zachor DA; Moore JF; Brezausek C; Theibert A; Percy AK
  • Start Page

  • 85
  • End Page

  • 97
  • Volume

  • 869
  • Issue

  • 1-2